Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Christopher Ronald Sarko is active.

Publication


Featured researches published by Christopher Ronald Sarko.


Bioorganic & Medicinal Chemistry Letters | 2009

A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties.

Neil Moss; Younggi Choi; Derek Cogan; Adam Flegg; Andreas Kahrs; Pui Loke; Orietta Meyn; Raj Nagaraja; Spencer Napier; Ashley Parker; J. Thomas Peterson; Philip Dean Ramsden; Christopher Ronald Sarko; Donna Skow; Josh Tomlinson; Heather Tye; Mark Whitaker

We have been exploring the potential of 5-HT(2B) antagonists as a therapy for chronic heart failure. To assess the potential of this therapeutic approach, we sought compounds possessing the following attributes: (a) potent and selective antagonism of the 5-HT(2B) receptor, (b) low impact of serum proteins on potency, and (c) desirable pharmacokinetic properties. This Letter describes our investigation of a biphenyl benzimidazole class of compounds that resulted in 5-HT(2B) antagonists possessing the above attributes. Improving potency in a human serum albumin shift assay proved to be the most significant SAR discovery.


Tetrahedron Letters | 2001

Microwave-assisted synthesis of a [3+2] cycloaddition library

Noel S. Wilson; Christopher Ronald Sarko; Gregory P. Roth

Abstract A novel method for the synthesis of a library of substituted prolines utilizing microwave-assisted synthesis is described. The process involves rapid microwave irradiation of α-aminoesters and aldehydes to generate imines followed by the addition of a dipolarophile and subsequent irradiation to produce the [3+2] cycloadducts. The decrease in reaction time afforded by microwave irradiation allowed for the production of an 800-membered solution-phase library in twofold less time than by traditional thermal methods. These products were purified by solid-supported reagent scavenging to furnish the desired products in high yields and purity.


Tetrahedron Letters | 2002

Microwave-assisted synthesis of 2-aminoquinolines

Noel S. Wilson; Christopher Ronald Sarko; Gregory P. Roth

An improved method for the synthesis of 2-aminoquinolines utilizing microwave-assisted synthesis is described. The process involves rapid microwave irradiation of secondary amines and aldehydes to form enamines followed by the addition of 2-azidobenzophenones with subsequent irradiation to produce the 2-aminoquinoline derivatives. Purification of the products is accomplished in a streamlined manner using solid-phase extraction techniques to produce the desired products in high yields and purity.


High Throughput Analysis for Early Drug Discovery | 2004

2 – Analysis of a Combinatorial Library Synthesized Using a Split-and-Pool Irori MicroKan Method for Development and Production

Heewon Lee; Christopher Ronald Sarko

Publisher Summary This chapter discusses the analytical methods and techniques used in the combinatorial chemistry group for 100% quality control (QC) analysis during the development and production of the libraries. It also describes automated solid phase extraction (SPE) methods as high throughput purification of combinatorial libraries. These multidimensional libraries can be quickly assembled from small sets of reagents producing very large libraries. Chemical tagging techniques in split-and-pool synthesis prevents the time-consuming deconvolution steps required in early syntheses; however, chemical tags may not be compatible with all relevant chemistries. An alternative for this is radio frequency (RF) tagging microchips. Incorporation of a discrete tag allows for individual compound generation while tracking compound identity. Such a synthetic vessel is the Irori MicroKan. This vessel can hold 30 mg of solid support and encase the RF tag, thus combining identity and individuality of the compounds. Combinatorial libraries generated by the Irori MicroKan method benefit from the split-and-pool synthesis on solid support and from the parallel synthesis technique producing one target compound per well without the need for deconvolution. Employing efficient and effective software is essential for the massive analytical data processing and presentation. New technologies to enhance the purity and quality of the library, including culling and reformatting procedures, high throughput chromatographic purification, and supercritical fluid chromatography (SFC), are continuously explored.


Bioorganic & Medicinal Chemistry Letters | 2007

Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors.

Roger J. Snow; Asitha Abeywardane; Scot Campbell; John Lord; Mohammed A. Kashem; Hnin Hnin Khine; Josephine King; Jennifer A. Kowalski; Steven S. Pullen; Teresa Roma; Gregory P. Roth; Christopher Ronald Sarko; Noel S. Wilson; Michael P. Winters; John P. Wolak; Charles L. Cywin


Journal of Medicinal Chemistry | 2006

Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies

Tina Morwick; Angela Berry; Janice R. Brickwood; Mario G. Cardozo; Katrina Mary Catron; Molly Deturi; Jonathan Emeigh; Carol Ann Homon; Matt Hrapchak; Stephen P. Jacober; Scott Jakes; Paul Kaplita; Terence A. Kelly; John Ksiazek; Michel Liuzzi; Ronald L. Magolda; Can Mao; Daniel R. Marshall; Daniel W. McNeil; Anthony S. Prokopowicz; Christopher Ronald Sarko; Erika Scouten; Cynthia Sledziona; Sanxing Sun; Jane Watrous; Jiang Ping Wu; Charles L. Cywin


Archive | 2002

Benzimidazoles useful as protein kinase inhibitors

Charles L. Cywin; Jinbo Lee; Gregory P. Roth; Christopher Ronald Sarko; Roger J. Snow; Noel S. Wilson; Steven S. Pullen


Bioorganic & Medicinal Chemistry Letters | 2006

Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase

Abdelhakim Hammach; Antonio J.M. Jr Ridgefield Barbosa; Faith Gaenzler; Tazmeen N. Fadra; Daniel R. Goldberg; Ming-Hong Hao; Rachel R. Kroe; Pingrong Liu; Kevin Chungeng Qian; Mark Ralph; Christopher Ronald Sarko; Fariba Soleymanzadeh; Neil Moss


Archive | 2009

Pyrazole Compounds As CCR1 Antagonists

Brian Nicholas Cook; Christian Harcken; Thomas Wei-Ho Lee; Pingrong Liu; Jord Lord; Can Mao; Wang Mao; Brian Christopher Raudenbush; Hossein Razavi; Christopher Ronald Sarko; Alen David Swinamer


Archive | 2003

Heterocyclic amide derivatives as cytokine inhibitors

Donghong Amy Gao; Daniel R. Goldberg; Abdelhakim Hammach; Ming-Hong Hao; Neil Moss; Kevin Chungeng Qian; Gregory P. Roth; Christopher Ronald Sarko; Alan David Swinamer; Zhaoming Xiong; Victor Marc Kamhi

Collaboration


Dive into the Christopher Ronald Sarko's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge